Rapport Therapeutics, Inc. (RAPP) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$87.47M | -34.9% |
| 2024 | -$64.83M | -138.5% |
| 2023 | -$27.18M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$87.47M | -34.9% |
| 2024 | -$64.83M | -138.5% |
| 2023 | -$27.18M | — |